Park Medi World IPO is a book-built issue worth ₹920.00 crore. The issue is a combination of fresh issue of 4.75 crore shares aggregating to ₹770.00 crores and offer for sale of 0.93 crore shares aggregating to ₹150.00 crore. The IPO will open for subscription on December 10, 2025, and close on December 12, 2025.
The basis of allotment is expected to be finalised on December 15, 2025, with tentative listing scheduled on BSE and NSE for December 17, 2025. The price band for the Park Medi World IPO has been fixed at ₹154 to ₹162 per share.
Investors can bid for Park Medi World IPO with a minimum of 1 lot, having 92 shares. For retail investors, the minimum investment required is ₹14,904. For high-net-worth investors (bHNI), the lot size stands at 68 lots, equal to 6,256 shares, amounting to ₹10,13,472.
Nuvama Wealth Management Ltd is the book running lead manager (BRLM), and Kfin Technologies Ltd is the registrar of the issue. Detailed information is available at the Park Medi World IPO RHP.
Park Medi World IPO Objectives
Park Medi World will use the funds raised from the public issue for the following:
- Repayment or prepayment, in full or in part, of certain outstanding borrowings taken by the Company and some of its Subsidiaries.
- Funding capital expenditures for the development of a new hospital and the expansion of an existing hospital by certain Subsidiaries, namely Park Medicity (NCR) and Blue Heavens, respectively.
- Funding capital expenditures for the purchase of medical equipment by the Company and specific Subsidiaries, including Blue Heavens and Ratangiri.
- Unspecified inorganic acquisitions and general corporate purposes.
About Park Medi World Limited
Incorporated in 2011, Park Medi World Limited is the second-largest private hospital chain in North India, with a total bed capacity of 3,000 beds, and holds the position of the largest private hospital network in Haryana, operating 1,600 beds within the state as of March 31, 2025.
It operates a network of 14 NABH-accredited multi-super-speciality hospitals under the “Park” brand, eight of which are also NABL-accredited. The network comprises eight hospitals in Haryana, one in New Delhi, three in Punjab, and two in Rajasthan, each dedicated to delivering high-quality and affordable healthcare across a broad spectrum of specialities.
The Company provides more than 30 super speciality and speciality services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology. As of September 30, 2025, its hospital network was supported by a team of 1,014 doctors and 2,142 nurses, ensuring comprehensive clinical services and patient care.
Industry Outlook
- The Indian healthcare delivery market reached approximately ₹6.9–7.0 trillion in FY 2025, driven by rising demand for routine treatments, elective surgeries, and OPD services.
- Critical Care, Oncology, Neurology, and Orthopaedics—segments that saw heightened demand post-pandemic—are expected to maintain strong growth momentum in FY 2025.
- Industry margins are projected to improve by 50–100 basis points to 18–19% in FY 2025, supported by higher ARPOB, enhanced operational efficiencies, and increased high-value medical tourism.
- In FY 2025, inpatient (IPD) services are estimated to contribute 71–72% of the market’s value despite OPD volumes being higher, reinforcing IPD’s role as the primary revenue driver in healthcare delivery.
How To Apply for the Park Medi World IPO Online?
- Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
- Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the Park Medi World IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
How To Check the Allotment Status of Park Medi World IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
Contact Details of Park Medi World IPO
12, Meera Enclave, Near Keshopur, Bus Depot, Outer Ring Road, New Delhi 110 018, Delhi
- Phone 91 124 6960000
- E-mail:company.secretary@parkhospital.in
Park Medi World IPO Reservation
| Investor Category | Shares Offered |
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII Shares Offered | Not less than 15% of the Offer |
Park Medi World IPO Lot Size Details
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 92 | ₹14,904 |
| Retail (Max) | 13 | 1,196 | ₹1,93,752 |
| S-HNI (Min) | 14 | 1,288 | ₹2,08,656 |
| S-HNI (Max) | 67 | 6,164 | ₹9,98,568 |
| B-HNI (Min) | 68 | 6,256 | ₹10,13,472 |
Park Medi World IPO Promoter Holding
Dr. Ajit Gupta and Dr. Ankit Gupta are the promoters of the company.
| Share Holding Pre-Issue | 95.55% |
| Share Holding Post Issue | 82.89% |
Note: Equity dilution will be determined by subtracting the Shareholding Post Issue from the Shareholding Pre Issue.
Key Performance Indicators for Park Medi World IPO
| KPI | Value |
| ROE (%) | 20.68 |
| ROCE (%) | 17.47 |
| RoNW (%) | 20.08 |
| PAT Margin (%) | 15.30 |
| EBITDA Margin (%) | 26.71 |
Park Medi World IPO Registrar and Lead Managers
Park Medi World IPO Lead Managers
Nuvama Wealth Management Ltd.
Registrar for Park Medi World IPO
Kfin Technologies Ltd.
Contact Number:+91 40 6716 2222
Email Address:parkmedi.ipoo@kfintech.com
Financial Performance of Park Medi World Limited
| Particulars | Period Ended on Sep 30, 2025 | Year ending on March 31, 2025 | Year ending on March 31, 2024 | Year ending on March 31, 2023 |
| Revenue from Operations (in ₹ Mn) | 8,086.57 | 13,935.70 | 12,310.66 | 12,545.95 |
| EBITDA (in ₹ Mn) | 2,171.36 | 3,721.73 | 3,103.01 | 3,903.41 |
| EBITDA Margin (%) | 26.85 | 26.71 | 25.21 | 31.11 |
| Profit/loss After Tax (in ₹ lakhs) | 1,391.43 | 2,132.15 | 1,520.07 | 2,281.86 |
| PAT Margin (%) | 17.21 | 15.30 | 12.35 | 18.19 |
| Debt to Equity Ratio (x) | 0.58 | 0.61 | 0.73 | 0.79 |
| Net Worth (in ₹ lakhs) | 11,530.46 | 10,218.64 | 8,159.77 | 6,675.49 |
Park Medi World Limited Peer Comparison
| Name of Company | Face Value (₹ per Share) | P/E | EPS (₹) Basic | RONW (%) |
| Park Medi World Limited | 2 | [●] | 5.55 | 20.08% |
| Apollo Hospitals Enterprise Limited | 5 | 73.43 | 100.56 | 17.63% |
| Fortis Healthcare Limited | 10 | 90.42 | 10.26 | 8.69% |
| Narayana Hrudayalaya Limited | 10 | 50.10 | 38.90 | 21.80% |
| Max Healthcare Institute Limited | 10 | 101.54 | 11.07 | 11.47% |
| Krishna Institute of Medical Sciences Limited | 2 | 69.53 | 9.61 | 17.89% |
| Global Health Limited | 2 | 66.41 | 17.92 | 14.27% |
| Jupiter Lifeline Hospitals Ltd | 10 | 48.59 | 29.47 | 14.27% |
| Yatharth Hospital & Trauma Care Services Ltd | 10 | 52.85 | 14.72 | 8.15% |
Strengths and Opportunities of Park Medi World Limited
- Positioned as the second-largest private hospital chain in North India and the largest in Haryana.
- Known for delivering high-quality, affordable healthcare across a diverse speciality mix.
- Proven capability in acquiring and seamlessly integrating hospitals.
- Demonstrates strong operational and financial performance with a well-diversified payor mix.
- Guided by a doctor-led professional management team with deep industry expertise.
- Aims to expand its hospital network through both organic growth and strategic acquisitions in North India.
- Plans to strengthen its presence in adjacent markets using a cluster-based expansion approach.
- Focused on enhancing occupancy, scaling newer hospitals, and improving efficiency through investments in advanced technology and high-end equipment.
Risks and Threats of Park Medi World Limited
- High contingent liabilities and substantial corporate guarantees pose potential financial strain if they materialise.
- Any downgrade in credit ratings could raise borrowing costs and impact financial performance.
- Declines in revenue and profitability or rising operating costs may adversely affect financial stability.
- High doctor attrition and dependence on medical professionals could disrupt operations and impact service quality.
- Heavy revenue concentration in Haryana exposes the business to region-specific risks and disruptions.
- Inability to pass rising operational costs to patients may compress margins and weaken financial results.
- Failure to realise expected benefits from acquisitions or tointegrate new hospitals could hinder growth prospects.
- Delays or underperformance in developing proposed hospitals may affect capacity, revenues, and long-term prospects.
